Peace of Mind: Pass Your Medical Oncology MOC Board Exam The First Time – Guaranteed!
-
Pass Your ABIM® Medical Oncology MOC Exam or:
- 1. Receive a 100% Refund of Your Course Tuition, Plus
- 2. Get an Additional $500, Plus
- 3. Take the Course Until You Pass, Tuition-Free!
The Pass Machine – The Power Behind this Learning System
Dear Colleague,
Imagine the peace of mind that you’ll experience once you’ve passed and this immense exam is behind you.
Thousands of physicians every year credit The Pass Machine course with their board exam success – and it is guaranteed to work for you. Here’s what makes The Pass Machine Medical Oncology MOC Board Review so effective:
“An excellent course. I would not want to face the exam without the information provided in this course.” Christopher Capel, MD, Casa Grande, AZ
HIGH-YIELD CONTENT
Laser-Focused Lectures: Content strictly follows the ABIM® Medical Oncology MOC exam blueprint. You review only what’s expected on your exam and nothing else.
The “QBL” Method: To ensure pinpoint exam relevancy, the lectures use a method called “Question-Based Learning.” Lectures are constructed from a series of board-style multiple choice questions, each coupled to a mini-lecture on that question’s topic.
Top-Flight Faculty: Lectures are presented by experienced, board-certified faculty from top teaching universities. Further, our two levels of medical editing ensure every lecture is up-to-date, medically accurate and 100% board-relevant.
ANYTIME, ANYWHERE ACCESS
Always-on Convenience: The Pass Machine Medical Oncology MOC Board Review course is optimized for 24/7 online access from any computer, smartphone, or tablet device, including the iPad® so you can watch the lectures and take practice exams whenever you have a free moment.
Detailed Printed Syllabus: The course syllabus includes all the lecture content mailed to you as soon as you register. Perfect for offline review!
Instant Gratification: Register today, start tonight! Plus, earn up to 38.5 AMA/PRA Category 1 CME credits. Course access is available for a full 12 18 months when you register now.
“The course is well organized, useful, and is a very good review for the Anesthesia board. Without hesitation, I would recommend it to anyone.” Gassan Mohama, MD, Chicago, IL
BOARD-STYLE PRACTICE EXAMS
Deep Question Bank: Test your exam preparedness with 300 exam-style multiple-choice questions (MCQ). Questions carefully follow the board content outline, so each one is relevant to your preparation.
Realistic Test Environment: Your patients test you every day – but not in the same way the boards test you. Learn how to answer questions in the board exam format. It’s as close as you can get to the real exam!
Optimized for Learning: Every MCQ includes a detailed, referenced explanation. That way you’re not just testing your knowledge – you’re learning the “how” and “why” behind every board-style question.
Register Today and Start Studying Tonight!
“Without the course, I felt overwhelmed at the sheer amount of material to read and learn. However, the course brought the material to life, and allowed me to focus on the material that was most important.” Ali Aurangzeb, MD, Meriden, CT
Why not take advantage of the fact that The Pass Machine course is available right now? You can register online or by calling our offices, which are open seven days a week, and start studying tonight! Once registered, you'll be granted access to your online dashboard with all course-related materials. We'll then ship your printed syllabus the next business day.
So turn the wasted energy of worrying about your approaching exam into useful, high-yield prep starting right now! And remember that The Pass Machine stands behind you all the way until you pass. You have my word – and guarantee – on that!
So, don't waste another moment. There really is a better way to learn. So please take a few moments to register now – you won't regret your decision.
Respectfully,
Jack Krasuski, MD
Executive Director
Add the Mobile Learning Package & Get a New iPad®
The Pass Machine course is formatted for study on the iPad. That is why the The Pass Machine course offers a $500 stipend to purchase the iPad or other tablet computer of your choice. That way you get the technology that is best suited to your exam preparation – and the flexibility of watching webinars and taking practice exams on your new iPad!
ONLINE COURSE AGENDA
Faculty
Mark Agulnik, MD
Titles/Affiliations/Positions:
- Assistant Professor, Division of Hematology and Oncology, Northwestern University, Chicago, IL
- Fellowship Director, Department of Medicine, Division of Hematology/ Oncology, Northwestern University, Chicago, IL
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
Education:
- MD, McGill University, Montréal, Québec Canada
- Residency, Internal Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
- Fellowship, Hematology and Medical Oncology, University of Illinois at Chicago, Chicago, IL
- Fellowship, Clinical Research, University of Toronto, Toronto, Ontario, Canada
Dr. Agulnik has recently received the Feinberg School of Medicine “Outstanding Teacher Award” at Northwestern University. He has been published in various outlets such as the American Society of Clinical Oncology, International Journal of Clinical Oncology, and Journal of the National Cancer Institute. Dr. Agulnik’s research includes studying the role and use of molecular targeting agents, novel chemotherapeutics, and new approaches for combined chemoradiotherapy for sarcomas and cancers of the head and neck.
Morey A. Blinder, MD
Titles/Affiliations/Positions:
- Associate Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
- Associate Member, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
- Medical Director, Wohl Hematology Laboratory, Washington University School of Medicine, St. Louis, MO
- Medical Staff, Barnes-Jewish Hospital, St. Louis, MO
Board Certifications:
- Internal Medicine, Medical Oncology, and Hematology, American Board of Internal Medicine
Education:
- MD, St. Louis University School of Medicine, St. Louis, MO
- Residency, University of Illinois School of Medicine, Chicago, IL
- Fellowship in Hematology, Department of Internal Medicine, University of Washington School of Medicine, Seattle, WA
Dr. Blinder has more than 15 years experience in lecturing at board review courses at Washington University in St. Louis, Missouri. He also has extensive experience teaching fellows and residents, as well as lecturing for numerous regional and national meetings and Grand Rounds. He also serves on the Missouri Genetic Disease Advisory Committee. Dr. Blinder’s board review lectures are described as exceptionally organized and delivered.
Tanios Bekaii-Saab, MD
Titles/Affiliations/Positions:
- Associate Professor of Medicine (with tenure), The Ohio State University-James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology-Oncology, Columbus, OH
- Medical Director, Gastrointestinal Oncology, The Ohio State University-James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology-Oncology, Columbus, OH
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, American University of Beirut, Lebanon
- Residency, Internal Medicine, Indiana University Medical Center, Indianapolis, IN
- Fellowship, Hematology-Oncology, Tufts-New England Medical Center, Boston, MA
- Fellowship, Clinical Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA
Dr. Saab has recently been awarded “Top Doctor” by Castle Connolly, “America’s Top Oncologist” in Gastrointestinal Oncology and a “Clinical Investigator Team Leadership Award” from the National Cancer Institute. He is an editorial board member for HemOnc Today, US Oncological Review, and World Journal of Hepatology. Dr. Saab also served as Chair for Gastrointestinal Cancers: A Multidisciplinary Approach to Prevention, Diagnosis and Treatment and as a Course Director for ASCO Review 2011.
Adam Brufsky, MD , PhD, FACP
Titles/Affiliations/Positions:
- Professor of Medicine, University of Pittsburgh, Pittsburgh, PA
- Director, Academic Medical Oncology, University of Pittsburgh Cancer Centers, Pittsburgh, PA
- Co-Director, Magee-Women’s Hospital/UPCI Comprehensive Breast Cancer Center, Pittsburgh, PA
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, University of Connecticut School of Medicine, Farmington, CT
- Residency, Internal Medicine, Brigham and Women’s Hospital, Boston, MA
- Fellowship, Medical Oncology, Bone Marrow Transplantation, Dana-Farber Cancer Institute, Boston, MA
Dr. Brufsky has published numerous abstracts and research articles in leading journals, including the Journal of Clinical Investigation, Journal of Clinical Oncology and Lancet. Dr. Brufsky is principal investigator on a number of research grants funded by the National Institutes of Health, the Susan G. Komen Foundation and the U.S. Army Breast Cancer Research Program. He is currently the principal investigator of the Pittsburgh Breast Cancer Consortium, a U.S. Department of Defense-funded program to increase community access to innovative clinical trials for the treatment of metastatic breast cancer, as well as a number of other breast cancer studies.
Matthew S. Davids, MD
Titles/Affiliations/Positions:
- Instructor, Harvard Medical School, Boston, MA
- Attending Physician, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, Yale Medical School, New Haven, CT
- Residency, Internal Medicine, New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center, New York City, NY
- Fellowship, Hematology and Oncology, Dana-Farber Cancer Institute; Brigham and Women’s Hospital; and Massachusetts General Hospital, Boston, MA
Dr. Davids conducts translational research in chronic lymphocytic leukemia (CLL) at the Dana Farber Cancer Institute. Dr. Davids has been awarded the “Chronic Lymphocytic Leukemia Foundation Award,” the ASCO Cancer Foundation “Merit Award,” and the “Cancer Education Consortium Award: Clinical Pharmacology of Anticancer Agents.”
Mellar P. Davis, MD
Titles/Affiliations/Positions:
- Professor, Cleveland Clinic, Cleveland, OH
- Director, Clinical Fellowship Program, Palliative Medicine and Supportive Oncology Services, Case Western Reserve University, Cleveland, OH
- Staff Physician, Cleveland Clinic Foundation/Taussig Cancer Center, Cleveland, OH
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Palliative Medicine, American Board of Hospice and Palliative Medicine
Education:
- MD, Ohio State University, Columbus, OH
- Residency, Internal Medicine, Riverside Methodist Hospital, Columbus, OH
- Fellowship, Hematology/Oncology, Mayo Clinic, Rochester, MN
Dr. Davis is an internationally recognized leader for his work in supportive and palliative care in oncology. He is currently on the Editorial Board for the Journal of Supportive Care in Cancer and the Editor-in-Chief for Progress in Palliative Care. He is also the Chairman of the Palliative Section of the Multinational Association of Supportive Care in Cancer. He has received numerous awards including “Palliative Medicine Teacher of the Year,” “Best Doctors in Oncology,” and “America’s Top Doctors for Cancer.”
Agustin A. Garcia, MD
Titles/Affiliations/Positions:
- Associate Professor, Division of Oncology, University of Southern California, Los Angeles, CA
- Director Clinical Research, Women’s Cancer Program, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, Universidad Anahuac, Mexico City, Mexico
- Residency, Medical Oncology, Hospital de Oncologia, Centro Medico Nacional, Mexico City, Mexico
- Residency, Internal Medicine, University of Illinois at Urbana Champaign, Urbana, IL
- Fellowship, Medical Oncology, University of Southern California, Los Angeles, CA
Dr. Garcia currently sits on the Oncology Expert Panel for the Department of Health Services in Los Angeles County. He is a part of the Gynecologic Cancer Scientific Steering Committee-Ovarian Cancer Task Force for the National Cancer Institute. Dr. Garcia has written chapters in Gynecologic Tumor Board: Clinical Cases in Diagnosis and Management of Cancer of the Female Reproductive System, Synopsis of Gynecologic Oncology, and Textbook of Uncommon Cancer.
Rimas Lukas, MD
Titles/Affiliations/Positions:
- Assistant Professor of Neuro-Oncology, University of Chicago Medical Center, Chicago, IL
- Co-director, Neurology Medical Student Clerkship, University of Chicago Medical Center, Chicago, IL
Board Certifications:
- Neurology, American Board of Psychiatry and Neurology
- Neuro-Oncology, United Council for Neurologic Subspecialties
Education:
- MD, Rush University Medical Center
- Chief Resident of Neurology, University of Chicago Medical Center
- Neuro-oncology and Translational Neuroscience Fellowships, University of Chicago Medical Center
Dr. Lukas specializes in the treatment of primary and metastatic central nervous system tumors. He works on a multidisciplinary team that focuses on the management of patients with cancers affecting the nervous system. Dr. Lukas is also actively involved in the education of medical students, residents and fellows. His research interests include the development of clinical trials evaluating new techniques for brain tumor treatment.
Michael A. Morse, MD, MHS, FACP
Titles/Affiliations/Positions:
- Associate Professor, Duke University Medical Center, Durham, NC
- Attending Physician, Duke University Medical Center, Durham, NC
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
Education:
- MD, Yale University School of Medicine, New Haven, CT
- Residency, Internal Medicine, University of Washington, Seattle, WA
- Fellowship, Hematology/Oncology, Duke University Medical Center, Durham, NC
Dr. Morse as been named “Best Doctors in America” for the past 7 years and is the Associate Editor for Clinical Cancer Research and Cancer Investigation. He is currently the Editor-in-Chief, Expert Opinion on Biological Therapy. Dr. Morse has written and been published in over 100 journal articles and was a coauthor of Cancer Vaccines and Malignant Liver Tumors: Current and Emerging Therapies.
Merry Jennifer Markham, MD
Titles/Affiliations/Positions:
- Clinical Assistant Professor, Division of Hematology & Oncology, University of Florida, Gainesville, FL
- Program Leader, Gynecologic Oncology Program, University of Florida & Shands Cancer Center, Gainesville, FL
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, University of Miami School of Medicine, Miami, FL
- Residency, Internal Medicine, University of Florida, Gainesville, FL
- Fellowship, Hematology/Oncology, University of Florida, Gainesville, FL
Dr. Markham is highly involved in medical education, she is a medical school course director and frequent lecturer in the College of Medicine. She serves as a mentor and teacher of medical students, residents, and hematology-oncology fellows in the Department of Medicine, and she has received numerous awards for her teaching activities. She is also a member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American College of Physicians (ACP), the Society of Gynecologic Oncology (SGO), and numerous clinical trial cooperative groups.
Daniel Petrylak, MD
Titles/Affiliations/Positions:
- Professor of Medicine, Yale University, New Haven, CT
- Director, Genitourinary Oncology, Division of Hematology/Oncology, Yale University, New Haven, CT
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, Case Western Reserve University School of Medicine, Cleveland, OH
- Residency and Internship, Internal Medicine, Bronx Municipal Hospital, New York, NY
- Fellowship, Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
Dr. Petrylak, the Leader of Prostate Medical Oncology at Yale Cancer Center, is internationally known medical oncologist, leading the genitourinary cancers medical oncology team at Smilow Cancer Hospital and as director of the prostate cancer research group and co-director of the Signal Transduction Research Program. He has authored or co-authored numerous articles and abstracts appearing in such peer-reviewed journals as Cancer, Cancer Research, Clinical Cancer Research, Journal of the National Cancer Institute, Nature, Journal of Urology New England Journal of Medicine, and Journal of Clinical Oncology. In addition, Dr. Petrylak has presented his research at numerous medical conferences, had a plenary sessions at ASCO and the AUA this year. He has authored several book chapters, reviews and editorials about the treatment of cancers of the prostate, bladder and kidney.
Gregory Pennock, MD
Titles/Affiliations/Positions:
- Assistant Professor of Medicine, University of Central Florida, Orlando, FL
- Director, Clinical Trials, MD Anderson Cancer Center, Orlando, FL
- Leader, Melanoma/Sarcoma Specialty Section, MD Anderson Cancer Center, Orlando, FL
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, University of Texas, Galveston, TX
- Residency, Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
- Fellowship, Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
Dr. Pennock serves as medical director of clinical trials for MD Anderson Cancer Center Orlando and as team leader for the Melanoma/Sarcoma Specialty Section. Dr. Pennock was recently elected to the American Society of Clinical Oncology’s Cancer Education Committee for Melanoma/Skin Cancers. Additionally, he is a member of the American College of Physicians and the American Medical Association. His research interests include developing novel therapies for melanoma and sarcoma.
Tanguy Seiwert, MD
Titles/Affiliations/Positions:
- Assistant Professor of Medicine, University of Chicago, Chicago, IL
- Attending Physician, Section of Hematology/Oncology, University of Chicago, Chicago, IL
Board Certifications:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Education:
- MD, Johannes Gutenberg Universität Mainz, Germany
- Residency, Internal Medicine, Duke University Medical Center, Durham, NC
- Fellowship, Hematology/Oncology, University of Chicago, Chicago, IL
Dr. Seiwert has most recently been published in Cancer Research, Anti-Cancer Drugs, and Journal of Clinical Oncology. He has written chapters that appear in Head/Neck and Lung Oncology Self-Assessment Program, and The Chemotherapy Handbook, Squamous Cell Head and Neck Cancer. Dr. Seiwert has received numerous awards including an ASCO “Merit Award,” and an IASLC “Fellowship Award” for his work with head, neck, and lung cancer.
CME Accreditation
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.
Designation Statement:
PeerPoint Medical Education Institute designates the live and enduring material formats for this educational activity for a maximum of 38.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity was planned and produced in accordance with the ACCME Essentials.
Frequently Asked Questions
General Questions About The Medical Oncology MOC Prep Course
- Your Online Dashboard: All your recorded lectures, course handouts, practice exams, and CME credits are organized on your American Physician Institute dashboard. This centralized location of all course materials makes your preparation organized and stress-free. And it allows you access from anywhere at any time - 24/7!
- Each API course addresses every skill required on the Psychiatry Oral Board Exam—from the live patient interview and case presentation to examiners, to the written and video vignettes.
- Your Printed Syllabus: The detailed printed syllabus includes all the course lecture content, clearly formatted to help you follow along. This allows you to focus on highlighting critical concepts, annotating tips and reminders, and achieving the greatest possible recall of the material come test time.
Note: The CME Evaluation for the Live Program will not be posted online until the last day of the live lectures.
General Questions About The Triple Trust Guarantee
Why does American Physician Institute have such a guarantee when no other company does? The Triple Trust Guarantee is API’s way of demonstrating that it’s just as invested in your success as you are. After all, if you fail, API will pay a penalty. American Physician Institute will refund your Course tuition in full, provide you with a bonus and allow you continued access to the Course tuition-free until you pass your exam for as long as the exam is offered by the certifying board. The guarantee ensures API doesn’t get paid for effort, only for results.
General Questions About The Pass Machine
- The Pass Machine Courses are not just general reviews—they’re tailored specifically to the topics and approaches you need to know to pass your exams.
- Each Course is a full preparation system that includes hundreds of MCQs, online lecture review, mobile lecture review, and a hard copy of the Course syllabus.
- The Pass Machine demonstrates its confidence in its Courses and commitment to your success by offering you this Triple Trust Guarantee: if you don’t pass your exam, you get your Course tuition back, PLUS $500, PLUS you get to retake the Course for FREE until you do pass.
http://www.abim.org/specialty/medical-oncology.aspx
Why $52? API recognizes that your referral saves about $104 in advertising costs, and they think it’s only fair to pass those savings along to both of you. There’s no limit to the goodwill and gratitude you’ll inspire among your colleagues, and there’s no limit to how many colleagues you can refer. You can make referrals across specialties, too! See the full list of Courses at www.AmericanPhysician.com and consider making a referral today.